Page last updated: 2024-09-05

enzastaurin and thiazoles

enzastaurin has been researched along with thiazoles in 2 studies

Compound Research Comparison

Studies (enzastaurin)	Trials (enzastaurin)	Recent Studies (post-2010) (enzastaurin)	Studies (thiazoles)	Trials (thiazoles)	Recent Studies (post-2010) (thiazoles)
188	52	99	33,179	2,100	12,330

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Krett, NL; Rosen, ST; Rovedo, MA	1
Bovée, JV; Briaire-de Bruijn, IH; Gelderblom, H; Herpers, B; van de Water, B; van Oosterwijk, JG; van Ruler, MA	1

Other Studies

2 other study(ies) available for enzastaurin and thiazoles

Article	Year
Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurin. The Journal of investigative dermatology, 2011, Volume: 131, Issue:7 Topics: Antineoplastic Agents; beta Catenin; Cells, Cultured; Glycogen Synthase Kinase 3; Humans; Hyaluronan Receptors; Indoles; Lymphoma, T-Cell, Cutaneous; Protein Kinase C; Protein Kinase Inhibitors; Skin Neoplasms; TCF Transcription Factors; Thiazoles; Urea	2011
Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells. British journal of cancer, 2013, Sep-03, Volume: 109, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Chondrosarcoma; Dasatinib; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HeLa Cells; Humans; Indoles; Male; MCF-7 Cells; Middle Aged; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles; Tumor Suppressor Protein p53; Young Adult	2013

Article

Year

Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurin.

The Journal of investigative dermatology, 2011, Volume: 131, Issue:7

Topics: Antineoplastic Agents; beta Catenin; Cells, Cultured; Glycogen Synthase Kinase 3; Humans; Hyaluronan Receptors; Indoles; Lymphoma, T-Cell, Cutaneous; Protein Kinase C; Protein Kinase Inhibitors; Skin Neoplasms; TCF Transcription Factors; Thiazoles; Urea

2011

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells.

British journal of cancer, 2013, Sep-03, Volume: 109, Issue:5

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Chondrosarcoma; Dasatinib; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HeLa Cells; Humans; Indoles; Male; MCF-7 Cells; Middle Aged; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles; Tumor Suppressor Protein p53; Young Adult

2013